Procedure
Argon Laser Treatment
Argon Laser Treatment is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Treatment of Primary Type I Pterygia With Argon Laser
NCT03485001
completed
Bevacizumab Injection for Recurrent Pterygium
NCT02007174
unknownphase_2
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
NCT01123564
completedphase_3
Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)
NCT00000144
Clinical Trials (4)
Showing 4 of 4 trials
NCT03485001Not Applicable
Treatment of Primary Type I Pterygia With Argon Laser
NCT02007174
Bevacizumab Injection for Recurrent Pterygium
NCT01123564Phase 2
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
NCT00000144Phase 3
Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4